Novartis
NVS
NVS
1,080 hedge funds and large institutions have $18B invested in Novartis in 2021 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 368 increasing their positions, 409 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $19.8B → $18B (-$1.8B)
10% less repeat investments, than reductions
Existing positions increased: 368 | Existing positions reduced: 409
28% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 79
Holders
1,080
Holding in Top 10
4
Calls
$501M
Puts
$160M
Top Buyers
| 1 | +$394M | |
| 2 | +$73.4M | |
| 3 | +$60.9M | |
| 4 |
Natixis Advisors
Boston,
Massachusetts
|
+$60M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$57.6M |
Top Sellers
| 1 | -$178M | |
| 2 | -$157M | |
| 3 | -$60.8M | |
| 4 |
WG
Welch Group
Birmingham,
Alabama
|
-$29M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$25.7M |